← Back to Search

PREVENT Tool for Childhood Obesity

N/A
Waitlist Available
Led By Maura Kepper, Ph.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adolescents 12 to 19 years
Prior diagnosis of pediatric cancer (diagnosed <21 years of age)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-months
Awards & highlights

Study Summary

This study is evaluating whether a new technology may help improve health behaviors for adolescents.

Eligible Conditions
  • Cardiovascular Disease
  • Childhood Obesity

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fidelity of PREVENT Tool Implementation
Mean Change in Minutes of Moderate Physical Activity Per Week (From Self Report) Survey
Mean Change in Minutes of Vigorous Physical Activity Per Week (From Self Report) Survey
+2 more
Secondary outcome measures
Clinic-level Capacity for Sustainability as Measured by Provider Survey
Impact of PREVENT Tool on Mean Change in Patient's Body Mass Index (BMI)
Impact of PREVENT Tool on Patient's Attitudes Toward Behavior Change
+8 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Patients - PREVENT toolExperimental Treatment1 Intervention
Complete questionnaires at baseline (administered electronically or by mail; accelerometers administered by mail). Following baseline measurement, patients will be randomized and attend their clinic visit. Follow-up measures will be administered immediately following the clinic visit (within 48 hours) and 3-months after the clinic visit electronically and by mail Up to 10 patients will also take part in semi-structured interviews At the clinic visit, the provider will use PREVENT tool to discuss risk and deliver a tailored behavioral change plan inclusive of patient-centered community resources. PREVENT will calculate patient's overall risk for developing cardiovascular disease. Physical activity and food intake recommendations are tailored to current weight status and health behaviors using evidence-based recommendations.
Group II: Patients - Wait-List ControlActive Control1 Intervention
Complete questionnaires at baseline (administered electronically or by mail; accelerometers administered by mail). Following baseline measurement, patients will be randomized and attend their clinic visit. Follow-up measures will be administered immediately following the clinic visit (within 48 hours) and 3-months after the clinic visit electronically and by mail Up to 10 patients will also take part in semi-structured interviews A PREVENT action plan (behavior change prescription, community resources, and education) will be provided to the patient via email after the completion of the follow-up measurement.
Group III: ProvidersActive Control1 Intervention
All eligible providers will be sent questionnaires electronically to their email at baseline and follow-up. Providers will be invited to attend a training session to educate them on the PREVENT tool at baseline A subset of 5-10 providers will be recruited via email, at the baseline training,or by using snowball-sampling approach within the clinic to participate in qualitative in-depth interviews
Group IV: ParentsActive Control1 Intervention
-Semi-structured interviews

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,928 Previous Clinical Trials
2,297,023 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,814 Previous Clinical Trials
47,290,810 Total Patients Enrolled
Maura Kepper, Ph.D.Principal InvestigatorWashington University School of Medicine
1 Previous Clinical Trials
26 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~16 spots leftby Mar 2025